Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label highly active antiretroviral therapy (HAART). Show all posts
Showing posts with label highly active antiretroviral therapy (HAART). Show all posts
Tuesday, June 11, 2013

Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA® (efavirenz) in HIV-1 Infected Pediatric Patients | BMS Newsroom

›
We know that, Efavirenz (EFV, brand names Sustiva , Stocrin , Efavir etc.) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) ...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.